Call for proposals to support innovative manufacturing technologies and processes in the Union for medicines production (HERA) - CP-g-24-12

This section outlines the types of entities eligible for funding under this call, focusing on those involved in pharmaceutical innovation across the European Union and associated countries. The program targets a broad spectrum of organizations committed to enhancing medicine manufacturing capabilities, aiming to secure the supply chain and improve health preparedness.

This section details the specific types of projects and thematic areas supported by the call, emphasizing innovations in pharmaceutical manufacturing processes. The funding targets activities that contribute to more efficient, cost-effective, and resilient production of medicines and medical countermeasures.

This section provides an overview of the financial support available, specifying the type of instrument and the allocated budget for this particular topic. It outlines the direct financial contribution intended to drive innovation in medicine manufacturing.

This section outlines the key stipulations and operational conditions that applicants must adhere to throughout the application and project implementation phases. Adherence to these conditions is crucial for successful participation and ensuring compliance with the program's guidelines.

This section guides potential applicants through the process of submitting their proposals, detailing the procedural steps and how evaluation results are communicated. It provides essential information regarding the timeline and avenues for support.

This section identifies the foundational legal instruments and policy documents that establish and govern the funding program, ensuring transparency and legal compliance.